The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up
- 1 May 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 343 (8909) , 1309-1312
- https://doi.org/10.1016/s0140-6736(94)92464-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Early detection of gastric cancer.BMJ, 1990
- Gastric cancer: A 25-year reviewBritish Journal of Surgery, 1989
- ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCERThe Lancet, 1989
- Chemotherapy of gastric cancerCancer Treatment Reviews, 1988
- EFFECT OF CIMETIDINE ON SURVIVAL AFTER GASTRIC CANCERThe Lancet, 1988
- Resection line disease in stomach cancer. British Stomach Cancer Group.BMJ, 1984
- Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.Journal of Clinical Pathology, 1983
- Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982
- INTRAVASCULAR HÆMOLYSIS AND RENAL IMPAIRMENT AFTER BLOOD TRANSFUSION IN TWO PATIENTS ON LONG-TERM 5-FLUOROURACIL AND MITOMYCIN-CThe Lancet, 1980